6-K ·Filed Aug 14, 2026
Notable filing: 6-K
Actionable Insight • Neutral
This is a routine conference call announcement with no material content. Traders should monitor the call for potential updates on pipeline progress or financing status, but this filing alone provides no actionable information.
Latest settled — T+20d
IPHA ▼ -15.14% at T+20d
NEUTRAL call -15.14% · α vs SPY -13.15% · entry $2.18 → $1.85
Latest observation: T+49 -39.24% FF3 residual α
T+1d
+3.67%
call +3.67% · α +4.14%
$2.26
settled 2mo ago
T+5d
+3.67%
call +3.67% · α +5.04%
$2.26
settled 2mo ago
T+20d
-15.14%
call -15.14% · α -13.15%
$1.85
settled 6w ago
T+60d
Pending
in 13d
Price Chart
Loading chart...
Executive Summary
Innate Pharma filed a 6-K announcing a conference call and webcast scheduled for August 14, 2026, with management participation. No financial results, clinical data, or material business updates were disclosed in this filing.
Key Facts
- Conference call scheduled for August 14, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT
- Participants include CEO Jonathan Dickinson, COO Yannis Morel, CFO Frédéric Lombard, and VP IR Stéphanie Cornen
- No financial figures, clinical data, or material agreements disclosed in this filing
Financial Impact
No financial impact from this filing
Risk Factors
- No new risks identified; prior 20-F highlighted a funding gap and going concern risk, but this filing does not address that
Market Snapshot
Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (8 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-056913 |
| Document: a260814_6k.htm | 0001628280-26-056913 |
| Document: 0001628280-26-056913-index-headers.html | 0001628280-26-056913 |
| Document: 0001628280-26-056913-index.html | 0001628280-26-056913 |
| Document: 0001628280-26-056913.txt | 0001628280-26-056913 |
12 reports for IPHA
0% Hit rate @ T+20 Went positive at some point 0 of 3 best @ T+1▼ −0.52%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $1.57 | awaiting T+20 | — | $1.46 (−7.01%) |
Oct 20, 2026 6d ago | 6-K | $1.58 | awaiting T+20 | — | $1.46 (−7.48%) |
Sep 17, 2026 5w ago | 6-K | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.46 (−23.56%) |
Sep 17, 2026 5w ago | 6-K | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.46 (−23.56%) |
Sep 17, 2026 5w ago | 6-K | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.46 (−23.56%) |
Sep 16, 2026 5w ago | Press Release | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.46 (−23.56%) |
Sep 10, 2026 6w ago | 6-K | $1.88 $1.48 | ▼ −21.28% | ▼ −23.40% | $1.46 (−22.34%) |
Sep 2, 2026 7w ago | 6-K | $2.17 $1.63 | ▼ −24.88% | ▼ −24.80% | $1.46 (−32.72%) |
Aug 14, 2026 10w ago | 6-K | $2.18 $1.85 | ▼ −15.14% | ▼ −13.15% | $1.46 (−33.03%) |
Aug 10, 2026 11w ago | 6-K | $2.22 $2.05 | ▼ −7.66% | ▼ −6.74% | $1.46 (−34.23%) |
Showing 10 of 12
US Market Status
Market Closed — Opens Wed (10h 15m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers